Expert Rev Vaccines. 2009 Jun;8(6):689-93.

Protective immunity to influenza: lessons from the virus for successful vaccine design.

Source

Department of Cellular & Developmental Biology, University of Rome La Sapienza, Via dei Sardi, 70, 00185 Rome, Italy. bruno.garulli@uniroma1.it

Abstract

The development of an effective influenza vaccine would require the ability to protect against infection with multiple influenza viral strains. In particular, mucosal and T-cell-mediated immunity may offer a more cross-reactive vaccine approach for the prevention of epidemic or potentially pandemic influenza. Thus, it is imperative to more fully understand the molecular events that occur in the host upon infection with a live virus and, in particular, to better evaluate the role of the distinct signaling pathways involved in developing protective immune responses. The paper under evaluation here introduces the notion that activation of caspase-1 inflammasomes in the hematopoietic cells in vivo are required for the establishment of Th1, cytotoxic T-lymphocyte and IgA responses to influenza virus infection.

Comment on

J Exp Med. 2009 Jan 16;206(1):79-87.

PMID:: 19485749; [PubMed]

Publication Types

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Mucosal immunity induced by adenovirus-based H5N1 HPAI vaccine confers protection against a lethal H5N2 avian influenza virus challenge. [Virology. 2009]
Mucosal immunity induced by adenovirus-based H5N1 HPAI vaccine confers protection against a lethal H5N2 avian influenza virus challenge.
Park KS, Lee J, Ahn SS, Byun YH, Seong BL, Baek YH, Song MS, Choi YK, Na YJ, Hwang I, et al. Virology. 2009 Dec 20; 395(2):182-9.
Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus. [Vaccine. 2009]
Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus.
Van Reeth K, Braeckmans D, Cox E, Van Borm S, van den Berg T, Goddeeris B, De Vleeschauwer A. Vaccine. 2009 Oct 23; 27(45):6330-9.
Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus. [Vaccine. 2009]
Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus.
Kreijtz JH, Bodewes R, van den Brand JM, de Mutsert G, Baas C, van Amerongen G, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. Vaccine. 2009 Aug 6; 27(36):4983-9. Epub 2009 Jun 16.
Review Prospects for developing an effective particle-mediated DNA vaccine against influenza. [Expert Rev Vaccines. 2009]
Review Prospects for developing an effective particle-mediated DNA vaccine against influenza.
Yager EJ, Dean HJ, Fuller DH. Expert Rev Vaccines. 2009 Sep; 8(9):1205-20.
Review Influenza control in the 21st century: Optimizing protection of older adults. [Vaccine. 2009]
Review Influenza control in the 21st century: Optimizing protection of older adults.
Monto AS, Ansaldi F, Aspinall R, McElhaney JE, Montaño LF, Nichol KL, Puig-Barberà J, Schmitt J, Stephenson I. Vaccine. 2009 Aug 13; 27(37):5043-53. Epub 2009 Jun 24.

See reviews... See all...

Cited by 3 PubMed Central articles

Predicting interaction sites from the energetics of isolated proteins: a new approach to epitope mapping. [Biophys J. 2010]
Predicting interaction sites from the energetics of isolated proteins: a new approach to epitope mapping.
Scarabelli G, Morra G, Colombo G. Biophys J. 2010 May 19; 98(9):1966-75.
In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants. [Mol Pharm. 2010]
In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants.
Bachelder EM, Beaudette TT, Broaders KE, Fréchet JM, Albrecht MT, Mateczun AJ, Ainslie KM, Pesce JT, Keane-Myers AM. Mol Pharm. 2010 Jun 7; 7(3):826-35.
Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. [Crit Care. 2009]
Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza.
Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, Rello J, Almansa R, Ramírez P, Martin-Loeches I, Varillas D, Gallegos MC, Serón C, et al. Crit Care. 2009; 13(6):R201. Epub 2009 Dec 11.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Protective immunity to influenza: lessons from the virus for successful vaccine ...
Protective immunity to influenza: lessons from the virus for successful vaccine design.
Expert Rev Vaccines. 2009 Jun ;8(6):689-93.

PubMed
Post-traumatic stress disorder in the community: an epidemiological study.
Post-traumatic stress disorder in the community: an epidemiological study.
Psychol Med. 1991 Aug ;21(3):713-21.

PubMed
[Contribution of central venous oxygen saturation in postoperative blood transfu...
[Contribution of central venous oxygen saturation in postoperative blood transfusion decision].
Ann Fr Anesth Reanim. 2009 Jun ;28(6):522-30. Epub 2009 May 20 .

PubMed
Elevated blood cyanide concentrations in victims of smoke inhalation.
Elevated blood cyanide concentrations in victims of smoke inhalation.
N Engl J Med. 1991 Dec 19 ;325(25):1761-6.

PubMed
Cytomegalovirus infection in critically ill patients: a systematic review.
Cytomegalovirus infection in critically ill patients: a systematic review.
Crit Care. 2009 ;13(3):R68. Epub 2009 May 14 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Protective immunity to influenza: lessons from the virus for successful vaccine design.

Source

Abstract

Comment on

Publication Types

Publication Types

LinkOut - more resources

Full Text Sources

Other Literature Sources

Libraries

Supplemental Content

Save items

Related citations in PubMed

Cited by 3 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information